id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6765-0005,FDA,FDA-2017-D-6765,Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2022-08-17T04:00:00Z,2022,8,2022-08-17T04:00:00Z,,2022-08-17T12:11:22Z,2022-17643,0,0,090000648524485a
FDA-2017-D-6765-0004,FDA,FDA-2017-D-6765,Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Final Guidance,Other,Guidance,2022-08-16T04:00:00Z,2022,8,2022-08-17T04:00:00Z,,2024-11-12T23:44:23Z,,1,0,0900006485241126
FDA-2017-D-6765-0002,FDA,FDA-2017-D-6765,Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2017-12-18T05:00:00Z,2017,12,2017-12-18T05:00:00Z,2018-03-20T03:59:59Z,2022-08-17T12:02:10Z,,0,0,0900006482d34446
FDA-2017-D-6765-0001,FDA,FDA-2017-D-6765,Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2017-12-18T05:00:00Z,2017,12,2017-12-18T05:00:00Z,2018-03-20T03:59:59Z,2018-03-21T01:01:16Z,2017-27132,0,0,0900006482d30212